On the evening of August 15, Junshi Bio announced through its official account that the company had signed a strategic cooperation agreement with the Cancer Prevention and treatment Center of Sun Yat-sen University. The two sides will focus on "live bacteria biological agents for immunotherapy" and other tumor immunotherapy and autoimmune disease drugs, cooperate in technical research and development of new cancer drugs, clinical trials, and carry out personnel training cooperation in the field of medical innovation and clinical research.
君实生物：与中山大学肿瘤防治中心开展肿瘤新药合作
Junshi Biology: cooperate with the Cancer Prevention and treatment Center of Sun Yat-sen University on new cancer drugs
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.